Patent · US Active

NF-κB signaling pathway-manipulated dendritic cells

US9862968B2 · kind B2 · utility

0Cited by

0References

3Claims

0Family size

Assignee

FRIEDRICH-ALEXANDER-UNIVERSITÄT ERLANGEN-NÜRNBERG · DE

Inventors

Katrin Birkholz · Erlangen, DE
Jan Dörrie · Nuremberg, DE
Niels Schaft · Herzogenaurach, DE
Gerold Schuler · Spardorf, DE
Reinhard Voll · Eggolsheim, DE
Isabell Pfeiffer · Neustadt an der Aisch, DE

Key dates

Filing date	Oct 26, 2011
Grant date	Jan 9, 2018
Priority date	—
Expiry date	Dec 15, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to dendritic cells, the NFκB signaling pathway of which has been manipulated by RNA transfection, to the manufacture thereof and to use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.